DNA-BSA interaction, cytotoxicity and molecular docking of mononuclear zinc complexes with reductively cleaved N2S2 Schiff base ligands

Cytotoxicity and mechanism of action of metal complexes: An overview

After the discovery of cisplatin, many metal compounds were investigated for the therapy of diseases, especially cancer. The high therapeutic potential of metal-based compounds is related to the special properties of these compounds, such as their redox activity and ability to target vital biological sites. The overproduction of ROS and the consequent destruction of the membrane potential of mitochondria and/or the DNA helix is one of the known pathways leading to the induction of apoptosis by metal complexes. The apoptosis process can occur via the death receptor pathway and/or the mitochondrial pathway. The expression of Bcl2 proteins and the caspase family play critical roles in these pathways. In addition to apoptosis, autophagy is another process that regulates the suppression or promotion of various cancers through a dual action. On the other hand, the ability to interact with DNA is an important property found in several metal complexes with potent antiproliferative effects against cancer cells. These interactions were classified into two important categories: covalent/coordinated or subtle, and non-coordinated interactions. The anticancer activity of metal complexes is sometimes achieved by the simultaneous combination of several mechanisms. In this review, the anticancer effect of metal complexes is mechanistically discussed by different pathways, and some effective agents on their antiproliferative properties are explained.

Heteroligand α-Diimine-Zn(II) Complexes with O,N,O'- and O,N,S-Donor Redox-Active Schiff Bases: Synthesis, Structure and Electrochemical Properties

A number of novel heteroligand Zn(II) complexes (1-8) of the general type (Lⁿ)Zn(NN) containing O,N,O'-, O,N,S-donor redox-active Schiff bases and neutral N,N'-chelating ligands (NN) were synthesized. The target Schiff bases LⁿH₂ were obtained as a result of the condensation of 3,5-di-tert-butyl-2-hydroxybenzaldehyde with substituted o-aminophenols or o-aminothiophenol. These ligands with combination with 2,2'-bipyridine, 1,10-phenanthroline, and neocuproine are able to form stable complexes upon coordination with zinc(II) ion. The molecular structures of complexes 4∙H₂O, 6, and 8 in crystal state were determined by means of single-crystal X-ray analysis. In the prepared complexes, the redox-active Schiff bases are in the form of doubly deprotonated dianions and act as chelating tridentate ligands. Complexes 6 and 8 possess a strongly distorted pentacoordinate geometry while 4∙H₂O is hexacoordinate and contains water molecule coordinated to the central zinc atom. The electrochemical properties of zinc(II) complexes were studied by the cyclic voltammetry. For the studied complexes, O,N,O'- or O,N,S-donor Schiff base ligands are predominantly involved in electrochemical transformations in the anodic region, while the N,N'-coordinated neutral nitrogen donor ligands demonstrate the electrochemical activity in the cathode potential range. A feature of complexes 5 and 8 with sterically hindered tert-butyl groups is the possibility of the formation of relatively stable monocation and monoanion forms under electrochemical conditions. The values of the energy gap between the boundary redox orbitals were determined by electrochemical and spectral methods. The parameters obtained in the first case vary from 1.97 to 2.42 eV, while the optical bang gap reaches 2.87 eV.

Coordination compounds of biogenic metals as cytotoxic agents in cancer therapy

The review summarizes the data on the structures and methods for the synthesis of compounds with anticancer activity based on biogenic metals, which can replace platinum drugs prevailing in cytotoxic therapy. The main focus is given to the comparison of the mechanisms of the cytotoxic action of these complexes, their efficacy and prospects of their use in clinical practice. This is the first systematic review of cytotoxic zinc, iron, cobalt and copper compounds. The structure – activity relationships and the mechanisms of antitumour action are formulated for each type of metal complexes.

The bibliography includes 181 references.

Evaluation of the Anticancer and DNA-Binding Characteristics of Dichloro(diimine)zinc(II) Complexes

Several metal diimine complexes have been reported to possess anticancer properties. To evaluate the anticancer properties of tetrahedral zinc(II) diimine complexes, six complexes were synthesized with the general formula M(N^N)Cl2 {where M = Zn, Pt and N^N = 2,2’-biquinoline (1), 2,2’-dipyridylketone (2) and 4-((pyridine-2-ylmethylene)amino)phenol (3)}. In general, the intrinsic DNA-binding constants for the different compounds exhibited values within close proximity; the changes in the viscosity of the CT-DNA upon binding to the compounds suggest intercalation-binding mode. Molecular docking study predicted that complexes containing the highly planar ligand 2,2’-biquinoline are capable to establish π–π interactions with nucleobases of the DNA; the other four complexes engaged in donor–acceptor interactions with DNA nucleobases. The six complexes and two reference drugs (cisplatin and sunitinib) were tested against two cancer cell lines (COLO 205 and RCC-PR) and one normal cell line (LLC-MK2), highlighting the better performance of the zinc(II) complexes compared to their platinum(II) analogues. Moreover, zinc(II) complexes have higher selectivity index values than the reference drugs, with promising anticancer properties.

Structural characterization of new zinc(ii) complexes with N2O2 chelating thiosemicarbazidato ligands; investigation of the relationship between their DNA interaction and in vitro antiproliferative activity towards human cancer cells

New candidates to become DNA-targeting antiproliferative agents: Zinc(ii) complexes bearing N₂O₂-thiosemicarbazidato ligands.

Crystal structure of (E)-3-chloro-2-(((4-nitrophenyl)imino)methyl)phenol, C13H9ClN2O3

C13H9ClN2O3, orthorhombic, P212121 (no. 19), a = 7.401(3) Å, b = 12.005(5) Å, c = 13.808(5) Å, V = 1226.8(8) Å3, Z = 4, Rgt(F) = 0.0673, wRref(F2) = 0.1473, T = 293(2) K.

The synthesis of a Cu(ii) Schiff base complex using a bidentate N2O2 donor ligand: crystal structure, photophysical properties, and antibacterial activities

In this paper, a new mononuclear Cu(ii) complex was synthesized by using a bidentate N₂O₂ Schiff base ligand, (E)-2-bromo-4-chloro-6-[(2,6-dimethylphenylimino)methyl]phenol (HL), with a copper(ii) salt in a methanol solvent. The structures of the HL ligand and the complex were characterized by Fourier transform infrared (FTIR) spectroscopy, single crystal X-ray diffraction (SCXD), and elemental analysis (EA). The Cu(ii) center in the complex is four-coordinated by a bidentate N₂O₂ donor ligand, forming slightly distorted square planar geometry. The detailed studies of their photophysical properties such as UV-Vis and fluorescence were done and the X-ray diffraction (XRD) patterns were investigated in the powder forms. Density functional theory calculations were carried out on both the HL ligand and the Cu(ii) complex to investigate the changes in the structural parameters and energies of the HOMO and LUMO. The results demonstrated that the HOMO and LUMO were effectively separated with the benzene ring of 2,6-dimethylbenzenamine as the donor unit and the benzene ring of 3-bromo-5-chlorosalicylaldehyde as well as the chelate ring as the acceptor unit. The effective HOMO–LUMO separation helps induce intramolecular charge transfer from the HOMO to the LUMO. The HOMO–LUMO energy gap become smaller when the Schiff base ligand coordinated with Cu(ii) ions, which was most likely due to the Cu(ii) perturbation effect. These theoretical calculations supported the experimentally observed results. The antibacterial activities of the HL ligand and the Cu(ii) complex were studied on Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. The obtained data confirmed their potent antimicrobial activity and the Cu(ii) complex had the MIC value of 1.25 mmol L⁻¹ against Escherichia coli.

Reaction of a symmetric compartmental Schiff base ligand (HL) with copper(ii) salt in 2 : 1 M ratio in methanol gave rise to a mononuclear copper(ii) complex, which was characterized by single crystal X-ray diffraction studies.

Crystal structure of 2-((1H-benzo[d]imidazol-2-ylimino)methyl)-4,6-di-tert-butylphenol, C22H27N3O

C22H27N3O, monoclinic, P21/c (no. 14), a = 18.4984(4) Å, b = 11.4221(3) Å, c = 9.79600(19) Å, β = 90.9652(19)°, V = 2069.51(8) Å3, Z = 4, R gt(F) = 0.0605, wR ref(F 2) = 0.1773, T = 293(2) K.